Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukocyte immunoglobulin-like receptor pseudogenes are nonfunctional DNA segments highly homologous to functional LILR genes, which encode immunoregulatory receptor proteins in leukocytes. As a pseudogene (ENSG00000249189), it does not encode a functional protein, does not act as a receptor or other therapeutic target, and is not known to participate in cellular signaling or disease processes. Pseudogenes may occasionally produce noncoding RNAs or be transcribed at low levels, but by definition, they lack protein-coding capacity and established biological function. This target is considered incorrect for therapeutic purposes as it is a pseudogene, not a canonical, functional therapeutic target. No widely used standard alias is consistently found for ENSG00000249189, though names like "LILRP1" or "LILRP2" exist for other pseudogenes in the family. It should not be used as a canonical therapeutic target; functional members of the LILR family (e.g., LILRB1, LILRB2) are valid immune regulatory receptor drug targets.
None (no drugs act on this pseudogene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukocyte immunoglobulin-like receptor pseudogene.